SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Orchid BioSciences, Inc ORCH
An SI Board Since May 2000
Posts SubjectMarks Bans Symbol
94 18 0 ORCH
Emcee:  Mike McFarland Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1907:37 [ORCH,PEB] PE BIOSYSTEMS LICENSES ORCHID BIOSCIENCES' SNP-IT PRIMER EXSecret_Agent_Man-7/7/2000
18ORCH and GNSL shined todayThursday June 29, 6:27 pm edt Company Press Release Secret_Agent_Man-6/30/2000
17 Orchid aims to be a leader in the development and commercialization of techSecret_Agent_Man-6/24/2000
16 SNP Mining--The rush is on pubs.acs.orgMike McFarland-6/1/2000
15 This sector is not my forte but The Industry Standard has treated me well and tjohnsto1-6/1/2000
14 <The new SNPstream system, designed to score thousands of SNPs per day, wilMike McFarland-6/1/2000
13 Mike. How big is the Luminex news?johnsto1-5/31/2000
12 ORCH mentioned with big players-Celera- in last weeks cover story from Industryjohnsto1-5/31/2000
11 ORCHID AND LUMINEX ANNOUNCE COLLABORATION TO DEVELOP AUTOMATED SNP ASSAY SYSTEMMike McFarland-5/31/2000
10 People who say they get the top or buy the lows are often lying. Whatever systeReturn to Sender-5/20/2000
9 I've been using the rule: if the daily low and high are beaten each day, keOak Tree-5/20/2000
8 As long as the NIH is spending money, scientists at least will be buying biotecOak Tree-5/16/2000
7 I just have the sampler, after getting burned rushing into Sangamo on IPO day, Mike McFarland-5/16/2000
6 You're probably better off to stick with the more mature companies in the BReturn to Sender-5/15/2000
5 Have you looked at Caliper? Whats your take. At least they have financial stateOak Tree-5/15/2000
4 Question is are you loading up now? I have too much caliper though they do seemOak Tree-5/15/2000
3 >Still, one wonders if ten or 20 years from now big pharma will dare developReturn to Sender-5/6/2000
2 Orchid lists as its competitors in the area of SNP scoring as Affymetrix, AmersMike McFarland-5/6/2000
1 Can I include ORCH with those companies participating in the Human Genome ProjeReturn to Sender-5/5/2000
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News